Rapport Therapeutics, Inc. (RAPP)
39.50
+0.01
(+0.03%)
USD |
NASDAQ |
May 29, 16:00
39.44
-0.06
(-0.15%)
After-Hours: 20:00
Rapport Therapeutics Shareholders Equity (Quarterly) : 471.51M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EyePoint, Inc. | 230.47M |
| Biofrontera, Inc. | 6.07M |
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 497.60M |
| Total Liabilities (Quarterly) | 26.08M |
| Debt to Equity Ratio | 0.0229 |
| Current Ratio | 27.08 |
| Net Debt Paydown Yield | -0.12% |